A01K 2267/0381
Animal model for diseases of the hematopoietic system
A01K2267/0381 (Animal model for diseases of the hematopoietic system) appears on 229 US grants and 279 published applications in this corpus.
Search patents in A01K- Granted patents
- 229
- Published applications
- 279
- Assignees
- 174
- Inventors
- 542
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 11 | 0 |
| 1997 | 10 | 0 |
| 1998 | 9 | 0 |
| 1999 | 12 | 0 |
| 2000 | 21 | 0 |
| 2001 | 7 | 1 |
| 2002 | 7 | 9 |
| 2003 | 9 | 23 |
| 2004 | 4 | 11 |
| 2005 | 6 | 22 |
| 2006 | 5 | 14 |
| 2007 | 9 | 14 |
| 2008 | 6 | 9 |
| 2009 | 4 | 8 |
| 2010 | 2 | 8 |
| 2011 | 3 | 8 |
| 2012 | 2 | 9 |
| 2013 | 4 | 12 |
| 2014 | 4 | 11 |
| 2015 | 16 | 21 |
| 2016 | 9 | 12 |
| 2017 | 12 | 13 |
| 2018 | 4 | 14 |
| 2019 | 12 | 14 |
| 2020 | 8 | 12 |
| 2021 | 8 | 12 |
| 2022 | 2 | 6 |
| 2023 | 3 | 0 |
| 2024 | 10 | 9 |
| 2025 | 4 | 5 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically modified non-human animals expressing human EPO4 Aug 2026US 12,696,884 B2Institute for Research in Biomedicine (IRB)
- Engineered nucleases that target human and canine factor VIII genes as a treatment for hemophilia A7 Apr 2026US 12,595,470 B2Precision BioSciences, Inc.
- Mouse having a humanized b-cell activating factor gene3 Feb 2026US 12,538,905 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified mice and engraftment2 Sep 2025US 12,402,611 B2Regeneron Pharmaceuticals, Inc.
- Mouse having a humanized cluster of differentiation 47 gene19 Aug 2025US 12,389,889 B2Regeneron Pharmaceuticals, Inc.
- Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a23 Jul 2026US 2026/0209731 A1Precision BioSciences, Inc.
- Genetically Modified Mice and Engraftment5 Mar 2026US 2026/0060222 A1Institute for Research in Biomedicine (IRB)
- Genetically Modified Non-Human Animals And Methods Of Use Thereof6 Mar 2025US 2025/0072405 A1Institute for Research in Biomedicine (IRB)
- Product and method for treating thrombocytopenia13 Feb 2025US 2025/0049849 A1Shanghai Synvida Biotechnology Co. Ltd.
- Gene therapy of hemophilia a using viral vectors encoding recombinant fviii variants with increased expression6 Feb 2025US 2025/0043310 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,541US 5,661,016 AGenPharm International, Inc. · 1997
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Generation of xenogeneic antibodies639US 6,114,598 AAbgenix, Inc. · 2000
- Transgenic mice depleted in a mature lymphocytic cell-type491US 5,591,669 AGenPharm International, Inc. · 1997
- Transgenic mice depleted in mature T-cells and methods for making transgenic mice175US 5,175,384 AGenPharm International, Inc. · 1992